An AI startup is proposing FDA deregulation through an obscure loophole, aiming to ease regulatory constraints on AI health tech products; this move could significantly impact how AI technologies are brought to market, potentially speeding up availability but raising concerns about safety and efficacy for content creators in the health tech space.
Read the full article at STAT News
Want to create content about this topic? Use Nemati AI tools to generate articles, social posts, and more.





